The Journal of Korea Assosiation for Disability and Oral Health (대한장애인치과학회지)

Korean Association for Disability and Oral Health (대한장애인치과학회)
권호 표지
DOI QR코드

DOI QR Code

DENTAL TREATMENT USING TRIAZOLAM FOR THE MENTAL RETARDATION PATIENT : A CASE REPORT

Triazolam을 이용한 지적 장애인 환자의 치과 치료 : 증례보고

  • Lee, Soo Jeong (Division of Pediatric Dentistry, Department of Dentistry, Ajou University School of Medicine) ;
  • Baek, Kwangwoo (Division of Pediatric Dentistry, Department of Dentistry, Ajou University School of Medicine)
  • 이수정 (아주대학교병원 소아치과학교실) ;
  • 백광우 (아주대학교병원 소아치과학교실)
  • Received : 2015.11.24
  • Accepted : 2015.12.11
  • Published : 2015.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Mental retardation is one of the major disorders covered in special care dentistry. Patients show poor oral health and are a challenge for the dentist due to lack of cooperation. Triazolam is a short-acting benzodiazepine and has been used in the dental office for many years because of its favorable properties. In this study, five patients with mental retardation were sedated with triazolam on a dental out-patient setting. Patients were administrated with 0.25 mg or 0.5 mg of triazolam on the first dose according to the patient's cooperation. Twenty minutes after the initial dose, patients received 0.25 mg of triazolam. Triazolam was administrated sublingually to one patient and orally to four patients. Hydroxyzine was also administrated to three patients in order to prevent nausea and vomiting. All patients were inhaled with 50% nitrous oxide during the sedation. Treatment time ranged from 20 minutes to 55 minutes. Two patients showed paradoxical reactions and were administrated with intramuscular injections of flumazenil. In result, depending on the range of dental treatment and level of intellectual disability, we can assume that triazolam may be beneficial for sedation in disabled patients.

장애인의 보건 수준이 높아지면서 치료보다는 예방의 관점에서의 구강 관리가 중요해지고 있다. 본 증례에서 소개된 다섯 명의 지적 장애를 지닌 환자들을 triazolam을 이용하여 경구 투여하여 치료하였다. Triazolam을 이용한 진정법은 장애인의 정기적인 구강 관리의 한 대안으로 고려해볼 수 있겠다.

Keywords

References

  1. http://www.index.go.kr/potal/main/EachDtlPageDetail.do?idx_cd=2768
  2. Chang JH : Dental treatments or patients with severe mental challenges. KDA, 49:739-748, 2011.
  3. Kim YJ : Dental considerations for special care dentistry according to the types of disabilities, KDA, 49:732-738, 2011.
  4. Kim SO : A survey of non-emergency and emergency deep sedation using sevoflurane inhalation for pediatric or disabled patients, J of Korean Acad Pediatr Dent, 41:18-26, 2014. https://doi.org/10.5933/JKAPD.2014.41.1.18
  5. Faulks D, Hennequin M, Onody P, et al. : Sedation with 50% nitrous oxide/oxygen for outpatient dental treatment in individuals with intellectual disability. Dev Med Child Neurol, 49:621-625, 2007. https://doi.org/10.1111/j.1469-8749.2007.00621.x
  6. Yuzkat N, Cegin MB : Anesthesia Management of Patients with Mental Retardation. Medical science and discovery, 2:239-243, 2015.
  7. Ban MH, Chung SS : The Analysis of Outpatient Anesthesia for Dental Treatment in Handicapped Patients with Behavior Disorder. JKDSA, 14:57- 62, 2014.
  8. Cha MJ, Seo KS, Kim MS, Kim HJ : Analysis of Complications of Ambulatory General Anesthesia after Discharge in Patients Who are Taking Anticonvulsant. JKDSA, 14:95-100, 2014.
  9. Kong EK, Jung YJ, Baek KW : Dental Treatment for a Patient with Seizure History and Intellectual Disability under General Anesthesia: A Case Report. J Dent Anesth Pain Med, 8:35-39, 2008.
  10. Sostmann HJ, Crevoisier C, Bircher J : Dose equivalence of midazolam and triazolam. A psychometric study based on flicker sensitivity, reaction time and digit symbol substitution test. Eur J Clin Pharmacol, 36:181-187, 1989. https://doi.org/10.1007/BF00609192
  11. Raadal M, Coldwell SE, Karl HW, et al. : A randomized clinical trial of triazolam in 3- to 5-yearolds. J Dent Res, 78:1197-203, 1999. https://doi.org/10.1177/00220345990780060201
  12. Dionne R, Yagiela J, Donaldson M, et al. : Balancing efficacy and safety in the use of oral sedation in dental out-patients. J Am Dent Assoc, 137:502-513, 2006. https://doi.org/10.14219/jada.archive.2006.0223
  13. Kaufman E, Hargreaves KM, Dionne RA : Comparison of oral triazolam and nitrous oxide with placebo and intravenous diazepam for outpatient premedication. Oral Surg Oral Med Oral Pathol, 75:156-64, 1993. https://doi.org/10.1016/0030-4220(93)90086-J
  14. Donaldson M, Gizzarelli G, Chanpong B : Oral sedation: a primer on anxiolysis for the adult patient, Anesth Prog, 54:118-28, 2007. https://doi.org/10.2344/0003-3006(2007)54[118:OSAPOA]2.0.CO;2
  15. Berthold CW, Dionne RA, Corey SE : Comparison of sublingually and orally administered triazolam for premedication before surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 84:119-124, 1997. https://doi.org/10.1016/S1079-2104(97)90055-X
  16. Malamed SF : Sedation: A guide to patient management, 5th ed. St Louis, Mosby. 2010, pp 52-54, pp 97-4421.
  17. Scavone JM, Greenblatt DJ, Friedman H, Shader RI : Enhanced bioavailability of triazolam following sublingual versus oral administration. J Clin Pharmacol, 26:208-210, 1986. https://doi.org/10.1002/j.1552-4604.1986.tb02935.x
  18. Goodchild JH, Donaldson M : Calculating and justifying total anxiolytic doses of medications for in-office use. General dentistry, 54:545-7, 2006.
  19. Jackson DL, Milgrom P, Heacox GA, Kharasch ED : Pharmacokinetics and clinical effects of multidose sublingual triazolam in healthy volunteers. J Clin Psychopharmacol, 26:4-8, 2006. https://doi.org/10.1097/01.jcp.0000186742.07148.da
  20. Coldwell SE, Awamura K, Karl HW, et al. : Side effects of triazolam in children. Pediatr Dent, 21:18-25, 1999.